CD274 and neoplasm: PD-L1 is a main co-inhibitory immune checkpoint and the PD1/PD-L1 signaling is capable of mitigating the killing role of cytotoxic T cells within the tumor microenvironment, thus contributing to tumor immune evasion (28, 29).